Table 2. Clinical characteristics and biochemical observations for obese volunteers before and after weight loss surgery.
| ID | Sex | Age | DM | BMI (kg/m2) | Diabetes medication | Fasting glucose (mmol/L) | HbA1c (%) | Fasting free fatty acids (μmol/L) | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | ||||
| 1 | F | 37 | Yes | 54.8 | 33.5 | SU, TZD | None | 12.3 | 5.2 | 7.5 | 5.9 | 528 | 470 |
| 2 | M | 45 | Yes | 50.3 | 38.3 | Met, TZD | None | 9.6 | 5.4 | 7.9 | 5.4 | 763 | 1143 |
| 3 | M | 57 | Yes | 37.4 | 29.5 | Met, SU | None | 11.9 | 6.2 | 8.5 | 7.4 | 978 | 489 |
| 4 | F | 53 | Yes | 54.5 | 46.7 | Met, SU | None | 8.6 | 6.3 | 7.8 | 7.1 | 861 | 866 |
| 5 | F | 56 | No | 44.4 | 36.2 | None | None | 4.6 | 4.1 | 771 | 838 | ||
| 6 | F | 56 | No | 48.2 | 41.1 | None | None | 6.1 | 5.1 | 923 | 1005 | ||
| 7 | F | 49 | No | 41.5 | 32.9 | None | None | 6 | 4 | 1500 | 604 | ||
| 8 | F | 30 | No | 47.4 | 35.6 | None | None | 3.6 | 4.7 | 845 | 653 | ||
| Mean ± SEM | 47.9±3.5 | 47.3±2.2 | 37±1.9* | 7.8±1.2 | 5.1±0.3* | 7.9±0.2 | 6.5±0.5* | 896.1±98.6 | 758.5±86.3 | ||||
Abbreviations for medications as follows; sulphonylureas (SU), metformin (Met) and rosiglitazone (TZD). HbA1c was only measured in patients with diabetes.
* = significant difference pre vs post with p<0.05